We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Alvotech has signed a definitive merger agreement with special purpose acquisition company Oaktree Acquisition Corp II to form a publicly traded international biopharmaceutical company.